Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

Thyroid cancer (TC) is the most common endocrine malignancy. TC is classified as differentiated TC (DTC), which includes papillary and follicular subtypes and Hürthle cell variants, medullary TC (MTC), anaplastic TC (ATC), and poorly differentiated TC (PDTC). The standard of care in DTC consists of...

Descripción completa

Detalles Bibliográficos
Autores principales: Puliafito, Ivana, Esposito, Francesca, Prestifilippo, Angela, Marchisotta, Stefania, Sciacca, Dorotea, Vitale, Maria Paola, Giuffrida, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Ejemplares similares